The 5th Annual Targeted Pain Treatment® Conference held on March 31, 2023, at the Hilton Knoxville Airport, was a resounding success, drawing in a diverse group of participants from various medical fields. The conference's theme, "Awareness, Access, Application," proved to be timely and relevant, as it highlighted the crucial need for reevaluating pain management approaches in light of the ongoing opioid crisis. The speakers' presentations were exceptionally well-received, with attendees commending the emphasis on a multi-faceted approach to pain management and the exploration of non-controlled treatment options. One of the key takeaways was the advocacy for prioritizing functional outcomes over pain scores, recognizing that true pain relief goes beyond merely reducing discomfort. Save the date for next year's conference on March 22, 2024, at the Hilton Knoxville Airport.
Targeted Pain Treatment® is a federally registered trademark owned by Dr. Stephanie Vanterpool. Dr. Vanterpool developed and is responsible for the content contained in the TPT Toolkit.
What is Targeted Pain Treatment (TPT)?Targeted pain treatment is the process of accurately diagnosing the underlying cause of pain, and the targeting the treatment to the cause of pain. The goal is to effectively treat pain and improve function, while also reducing unnecessary opioid medication use. |
Why does TPT matter?Targeted Pain Treatment differs from other approaches to pain management by seeking to treat the true cause of pain, rather than focusing on lowering a patient's pain score. |
TPT ToolkitPurpose of the TPT Toolkit is to provide tools and information needed to help clinicians implement targeted pain treatment in their practices. These include decision aids, references, and other useful resources as developed and collated. The TPT Toolkit contains downloadable tools, templates and decision aids to help you practice Targeted Pain Treatment and infographics. To access the TPT Toolkit, please click here: TPT Toolkit Download (Your email address is required) |
Important LinksTennessee Chronic Pain Guidelines (3rd Edition) Vanterpool SG. Targeted pain treatment - Reduce opioids, reclaim relief. Journal of the Tennessee Medical Association. 2018 Mar;110(4):9-10. Pain Management Best Practices Inter-agency Task Force Report |
Resources for PatientsTPT Frequently Asked Questions Please note: Targeted Pain Treatment® is a federally registered trademark owned by Dr. Stephanie Vanterpool. Dr. Vanterpool developed and is responsible for the content contained in the TPT Toolkit. Webinar: Targeted Pain Treatment Webinar: Injections and Procedures - What, When, Why
|
* Emphasizing the need for a multi-faceted approach to pain management.
* Highlighting the limitations of opioids and the importance of exploring non-controlled treatment options.
* Recognizing the effectiveness and potential of buprenorphine as a treatment modality.
* Addressing the opioid crisis and the increase in opioid-related deaths.
* Encouraging targeted and individualized pain management strategies.
* Stressing the importance of proper assessment and diagnosis of pain sources.
* Promoting collaboration and networking between specialists for optimal patient outcomes.
* Discussing various treatment modalities, including neuromodulation and interventional pain management.
* Advocating for prioritizing functional outcomes over pain scores.
* Addressing the access to pain management services and the availability of different chronic pain treatments beyond opioids.
Download Infographics (email address required)
Currently the UT Graduate School of Medicine (UTGSM) is the sponsoring institution of 11 residency programs and 15 fellowships. The program directors of these training programs share a passion for the education, training and well-being of its GME trainees. Click here to learn about each of our departments and programs. The UTGSM is located on the University of Tennessee Medical Center's campus.
The University of Tennessee Graduate School of Medicine
The University of Tennessee Medical Center
1924 Alcoa Highway
Knoxville, TN 37920
Phone: 865-305-9290
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2023